Skip to main content

ADVERTISEMENT

dose-dense therapy

Research in Review
11/10/2016
JCP Editors
The use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy does not result in significant improvement in high-risk early breast cancer recurrence-free survival (RFS), according to a...
The use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy does not result in significant improvement in high-risk early breast cancer recurrence-free survival (RFS), according to a...
The...
11/10/2016
Journal of Clinical Pathways